Tracking intracavernously injected adipose-derived stem cells to bone marrow

Area of Science:

• Regenerative Medicine
• Urology
• Cell Biology

Background:

• Intracavernous stem cell (SC) injections show promise for treating erectile dysfunction (ED) in animal models.
• The in vivo distribution and fate of injected SCs following intracavernous administration are not well understood.
• Understanding cell migration is crucial for optimizing SC-based therapies for ED.

Purpose of the Study:

• To investigate the tissue distribution of adipose-derived stem cells (ADSCs) after intracavernous injection in a rat model.
• To determine the effect of cavernous nerve (CN) injury and cell allogenicity on ADSC distribution.

Main Methods:

• Adipose-derived stem cells (ADSCs) were isolated, cultured, and labeled with 5-ethynyl-2-deoxyuridine (EdU).
• Rats underwent either cavernous nerve (CN) crush injury or sham operation, followed by intracavernous injection of labeled ADSCs or penile smooth muscle cells (PSMCs).
• Tissue distribution was analyzed using histology and flow cytometry at 2 and 7 days post-injection.

Main Results:

• Injected ADSCs rapidly exited the penis and preferentially migrated to the femoral bone marrow within days.
• Cellular allogenicity did not significantly alter ADSC distribution in the bone marrow.
• Cavernous nerve (CN) injury significantly reduced the number of ADSCs in the bone marrow at 7 days post-injection, but not at 2 days.

Conclusions:

• Intracavernously injected ADSCs exhibit significant migration out of the penis, primarily to the bone marrow.
• Bone marrow is a potential reservoir or target for stem cells administered for ED.
• Cavernous nerve injury influences the retention of stem cells in the bone marrow, suggesting a complex interaction relevant to ED pathophysiology and therapy.